Invivyd (IVVD) Cash from Financing Activities (2020 - 2026)
Invivyd (IVVD) reported Cash from Financing Activities of $157.18 million for Q4 2025, compared with $77,000 a year earlier and up 169.5% from the prior quarter.
Invivyd (IVVD) Cash from Financing Activities (2020 - 2026) Analysis & Trends
For FY2025, Invivyd posted Cash from Financing Activities of $215.63 million, up 448.2% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $39.33 million in FY2024, $1.05 million in FY2023 (+106.5%), $506,000 in FY2022 (-99.9%) and $662.68 million in FY2021 (+411.5%).
- The Q4 2025 figure ranks as the highest quarterly Cash from Financing Activities since Q3 2021.
- Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 40.5%.
- The high point for year-over-year Cash from Financing Activities in five years was Q2 2023 (growth of 264.9%); the low point was Q2 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $58.31 million (Q3 2025), $131,000 (Q2 2025) and $10,000 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Invivyd | 168.01 Mn | -487.88 Mn | 13.01 Mn | 19.44 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.44 Mn |
| Mar 31, 2026 | -98,000.00 |
| Dec 31, 2025 | 157.18 Mn |
| Sep 30, 2025 | 58.31 Mn |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 39.10 Mn |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 270,000.00 |
| Mar 31, 2023 | 542,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 246,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | -749,000.00 |
| Sep 30, 2021 | 328.60 Mn |
Invivyd Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IVVD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IVVD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IVVD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();